Bridging mice to men: Using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans

Methods in Molecular Biology

Volumn 602, Issue , 2010, Pages 119-134

  Serreze, David V ^a   Niens, Marijke ^a   Kulik, John ^a   Dilorenzo, Teresa P ^b  

^a JACKSON LABORATORY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

"humanized" NOD mice; autoimmunity; HLA transgenics; T cells; Type 1 diabetes (T1D)

Indexed keywords

ANIMALIA; MUS; MUS MUSCULUS;

G6PC2 PROTEIN, HUMAN; G6PC2 PROTEIN, MOUSE; GLUCOSE 6 PHOSPHATASE; HLA ANTIGEN; INSULIN; PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; TRANSGENE; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE-6-PHOSPHATASE; HLA ANTIGENS; HUMANS; INSULIN; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PROTEINS; TRANSGENES;

EID: 77449107603     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-058-8_8     Document Type: Article

References (66)

1. Anderson, M. S. and Bluestone, J. A. (2005) The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23, 447-485. (Pubitemid 40563177)
2. Serreze, D. V. and Leiter, E. H. (2001) Genes and pathways underlying autoimmune diabetes in NOD mice, in Molecular Pathology of Insulin Dependent Diabetes Mellitus (von Herrath, M. G., ed.). Karger Press, New York, pp. 31-67.
3. Onengut-Gumuscu, S. and Concannon, P. (2006) Recent advances in the immunogenetics of human type 1 diabetes. Curr. Opin. Immunol. 18, 634-638. (Pubitemid 44311456)
4. Mellman, I. (2007) Private lives: reflections and challenges in understanding the cell biology of the immune system. Science 317, 625-627. (Pubitemid 47229954)
5. Aly, T. A., Ide, A., Jahromi, M. M., Barker, J. M., Fernando, M. S., et al. (2006) Extreme genetic risk for type 1A diabetes. Proc. Natl. Acad. Sci. USA 103, 14074-14079. (Pubitemid 44452982)
6. Erlich, H., Valdes, A. M., Noble, J., Carlson, J. A., Varney, M., et al. (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57, 1084-1092.
7. Hanson, M. S., Cetkovic-Cvrlje, M., Ramiya, V. K., Atkinson, M. A., MacLaren, N. K., et al. (1996) Quantitative thresholds of MHC class II I-E expressed on hematopoietically derived APC in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J. Immunol. 157, 1279-1287. (Pubitemid 126449645)
8. Lund, T., O'Reilly, L., Hutchings, P., Kanagawa, O., Simpson, E., et al. (1990) Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-Ä-chain or normal I-E a-chain. Nature 345, 727-729.
9. Miyazaki, T., Uno, M., Uehira, M., Kikutani, H., Kishimoto, T., et al. (1990) Direct evidence for the contribution of the unique I-Anod to the development of insulitis in non-obese diabetic mice. Nature 345, 722-724.
10. Singer, S. M., Tisch, R., Yang, X.-D. and McDevitt, H. O. (1993) An Abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells. Proc. Natl. Acad. Sci. USA 90, 9566-9570. (Pubitemid 23315826)
11. Slattery, R. M., Kjer-Nielsen, L., Allison, J., Charlton, B., Mandel, T., et al. (1990) Prevention of diabetes in non-obese diabetic IAk transgenic mice. Nature 345, 724-726.
12. Christianson, S. W., Shultz, L. D. and Leiter, E. H. (1993) Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice: relative contributions of CD4+ and CD8+ T lymphocytes from diabetic versus prediabetic NOD.NON-Thy 1a donors. Diabetes 42, 44-55. (Pubitemid 23013794)
13. Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., et al. (1990) 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344, 742-746. (Pubitemid 20120604)
14. Koller, B. H., Marrack, P., Kappler, J. W. and Smithes, O. (1990) Normal development of mice deficient in b2m, MHC class I proteins, and CD8+ T cells. Science 248, 1227-1230.
15. Serreze, D. V., Leiter, E. H., Christianson, G. J., Greiner, D. and Roopenian, D. C. (1994) MHC class I deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 43, 505-509. (Pubitemid 24064261)
16. Wicker, L. S., Leiter, E. H., Todd, J. A., Renjilian, R. J., Peterson, E., et al. (1994) 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43, 500-504. (Pubitemid 24064260)
17. Sumida, T., Furukawa, M., Sakamoto, A., Namekawa, T., Maeda, T., et al. (1994) Prevention of insulitis and diabetes in beta(2)-microglobulin-deficient non-obese diabetic mice. Int. Immunol. 6, 1445-1449. (Pubitemid 24296861)
18. Serreze, D. V., Choisy-Rossi, C.-M., Grier, A., Holl, T. M., Chapman, H. D., et al. (2008) Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8 Tcells in NOD mice. J. Immunol. 180, 3250-3259.
19. Nejentsev, S., Howson, J. M. M., Walker, N. M., Szeszko, J., Field, S. F., et al. (2007) Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLAA. Nature 450, 887-892. (Pubitemid 350231332)
20. Demaine, A. G., Hibberd, M. L., Mangles, D. and Millward, B. A. (1995) A new marker in the HLA class I region is associated with the age at onset of IDDM. Diabetologia 38, 622-628.
21. Fennessy, M., Metcalfe, K., Hitman, G. A., Niven,M., Biro, P. A., et al. (1994) A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Diabetologia 37, 937-944. (Pubitemid 24288035)
22. Honeyman, M. C., Harrison, L. C., Drummond, B., Colman, P. G. and Tait, B. D. (1995) Analysis of families at risk for insulindependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol. Med. 1, 576-582.
23. Mizota, M., Uchigata, Y., Moriyama, S., Tokunaga, K., Matsuura, N., et al. (1996) Age dependent association of HLA-A24 in Japanese IDDM patients. Diabetologia 39, 371-373. (Pubitemid 26064835)
24. Nakanishi, K., Kobayashi, T., Murase, T., Naruse, T., Nose, Y., et al. (1999) Human leukocyte antigen-A24 and-DQA1?0301 in Japanese insulin-dependent diabetes mellitus: independent contributions to susceptibility to the disease and additive contributions to acceleration of beta-cell destruction. J. Clin. Endocrinol. Metab. 84, 3721-3725. (Pubitemid 30645231)
25. Nejentsev, S., Reijonen, H., Adojaan, B., Kovalchuk, L., Sochnevs, A., et al. (1997) The effect of HLA-B allele on the IDDM risk defined by DRB1?04 subtypes and DQB1?0302. Diabetes 46, 1888-1892. (Pubitemid 27456426)
26. Nejentsev, S., Gombos, Z., Laine, A.-P., Veijola, R., Knip, M., et al. (2000) Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 49, 2217-2221.
27. Robles, D. T., Eisenbarth, G. S., Wang, T., Erlich, H. A., Bugawan, T. L., et al. (2002) Identification of children with early onset and high incidence of anti-islet autoantibodies. Clin. Immunol. 102, 217-224. (Pubitemid 34259255)
28. Tait, B. D., Colman, P. G., Morahan, G., Marchinovska, L., Dore, E., et al. (2003) HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens 61, 146-153. (Pubitemid 36549600)
29. Undlien, D. E., Lie, B. A. and Thorsby, E. (2001) HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trends Genet. 17, 93-100. (Pubitemid 32140789)
30. Geluk, A., van Meijgaarden, K. E., Fraken, K. L. M. C., Drijfhout, J. W., DSouza, S., et al. (2000) Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A0201 restricted CD8+ T cells in HLA-transgenic mice and humans. J. Immunol. 165, 6463-6471.
31. Shirai, M., Arichi, T., Nishioka, M., Nomura, T., Ikeda, K., et al. (1995) CTL responses of HLA-A2.1-transgenic mice specific for Hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-2.1. J. Immunol. 154, 2733-2742.
32. Serreze, D. V., Chapman, H. D., Varnum, D. S., Hanson, M. S., Reifsnyder, P. C., et al. (1996) B lymphocytes are essential for the initiation of T cell mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ignull mice. J. Exp. Med. 184, 2049-2053. (Pubitemid 26404497)
33. Wang, B., Andre, I., Gonzalez, A., Katz, J. D., Aguet, M., et al. (1997) Interferon-g impacts at multiple points during progression of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94, 13844-13849. (Pubitemid 28009672)
34. Kanagawa, O., Xu, G., Tevaarwerk, A. and Vaupel, B. A. (2000) Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-g receptor loci. J. Immunol. 164, 3919-3923. (Pubitemid 30169852)
35. Leiter, E. H. (1997) The NOD mouse: a model for insulin-dependent diabetes mellitus. Curr. Protocols Immunol. 24, 15.19.11-15.19.23.
36. Nagy, A., Gertsenstein, M., Vintersten, K. and Behringer, R. (2003) Manipulating the Mouse Embryo: A Laboratory Manual, third ed ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
37. Marron, M. P., Graser, R. T., Chapman, H. D. and Serreze, D. V. (2002) Functional evidence for the mediation of diabetogenic T cell responses by human HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Proc. Natl. Acad. Sci. USA 99, 13753-13758. (Pubitemid 35215453)
38. Takaki, T., Marron, M. P., Mathews, C. E., Guttman, S. T., Bottino, R., et al. (2006) HLA-A?0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J. Immunol. 176, 3257-3265.
39. Irwin, M. J., Heath, W. R. and Sherman, L. A. (1989) Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response. J ExpMed 170, 1091-1101. (Pubitemid 19250681)
40. Lieberman, S. M., Takaki, T., Han, B., Santamaria, P., Serreze, D. V., et al. (2004) Individual nonobese diabetic mice exhibit unique patterns of CD8 T cell reactivity to three islet antigens including the newly identified widely expressed dystrophia myotonica kinase. J. Immunol. 173, 6727-6734. (Pubitemid 39541058)
41. Jarchum, I., Baker, J. C., Yamada, T., Takaki, T., Marron, M. P., et al. (2007) In vivo cytotoxicity of insulin specific CD8+ T cells in HLA-A?0201 transgenic NOD mice. Diabetes 56, 2551-2560. (Pubitemid 47523263)
42. Mallone, R., Martinuzzi, E., Blancou, P., Novelli, G., Afonzo, G., et al. (2007) CD8+ T cell responses identify-cell autoimmunity in human type 1 diabetes. Diabetes 56, 613-621. (Pubitemid 46348452)
43. Ouyang, Q., Standifer, N. E., Qin, H., Gottlieb, P. A., Verchere, C. B., et al. (2006) Recognition of HLA-class I restricted-cell epitopes in type 1 diabetes. Diabetes 55, 3068-3074. (Pubitemid 44923644)
44. Panagiotopoulos, C., Qin, H., Tan, R. and Verchere, C. B. (2003) Identification of Äcell specific HLA class I restricted epitope in type 1 diabetes. Diabetes 52, 2647-2651. (Pubitemid 37339692)
45. Pinske, G. G. M., Tysma, O. H. M., Bergen, C. A. M., Kester, M. G. D., Ossendorp, F., et al. (2005) Autoreactive CD8 T cells associated with cell destruction in type 1 diabetes. Proc. Natl. Acad. Sci. USA 102, 18425-18430. (Pubitemid 43011242)
46. Standifer, N. E., Ouyang, Q., Panagiotopoulos, C., Verchere, C. B., Tan, R., et al. (2006) Identification of novel HLAA? 0201-restricted epitopes in recent onset type 1 diabetic subjects and antibody positive relatives. Diabetes 55, 3061-3067. (Pubitemid 44923643)
47. Toma, A., Haddouk, S., Briand, J. P., Camoin, L., Gahery, H., et al. (2005) Recognition of a subregion of human proinsulin by class I restricted T cells in type 1 diabetic patients. Proc. Natl. Acad. Sci. USA 102, 10581-10586. (Pubitemid 41061597)
48. Han, B., Serra, P., Amrani, A., Yamanouchi, J., Maree, A. F., et al. (2005) Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low affinity peptide. Nat. Med. 11, 645-652. (Pubitemid 40868305)
49. Krishnamurthy, B., Dudek, N., McKenzie, M. D., Purcell, A. W., Brooks, A. G., et al. (2006) Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J. Clin. Invest. 116, 3258-3265. (Pubitemid 44878640)
50. Jaeckel, E., Lipes, M. A. and von Boehmer, H. (2004) Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat. Immunol. 5, 1028-1035. (Pubitemid 41057722)
51. Nakayama, T., Abiru, N., Moriyama, H., Babaya, N., Liu, E., et al. (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435, 220-223. (Pubitemid 40685949)
52. Mukhopadhaya, A., Hanafusa, T., Jarchum, I., Chen, Y. G., Iwai, Y., et al. (2008) Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc. Natl. Acad. Sci. USA 105, 6374-6379. (Pubitemid 351758353)
53. Chen, Y.-G., Silveira, P., Osborne, M. A., Chapman, H. D. and Serreze, D. V. (2007) Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype. Diabetes 56, 424-430.
54. Ikehara, S., Ohtsuki, H., Good, R. A., Asamoto, H., Nakamura, T., et al. (1985) Prevention of type 1 diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc. Natl. Acad. Sci. USA 82, 7743-7747. (Pubitemid 16204425)
55. Ildstad, S. T., Chilton, P. M., Xu, H., Domenick,M. A. and Ray,M. B. (2005) Preconditioning of NOD mice with anti-CD8 mAb and co-stimulatory blockade enhances chimerism and tolerance and prevents diabetes while depletion of ÄTCR+ and CD4 T cells negates the effect. Blood 105, 2577-2584. (Pubitemid 40387062)
56. LaFace, D. W. and Peck, A. B. (1989) Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetesnonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes 38, 894-901. (Pubitemid 20022396)
57. Li, H., Kaufman, C. L., Boggs, S. S., Johnson, P. C., Patrene, K. D., et al. (1996) Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J. Immunol. 156, 380-388.
58. Mathieu, C., Castells, K., Bouillon, R. and Waer, M. (1997) Protection against autoimmune diabetes in mixed bone marrow chimeras. J. Immunol. 158, 1453-1457. (Pubitemid 127469973)
59. Nikolic, B., Takeuchi, Y., Leykin, I., Fudaba, Y., Smith, R. N., et al. (2004) Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity. Diabetes 53, 376-383. (Pubitemid 38174553)
60. Serreze, D. V. and Leiter, E. H. (1991) Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hematopoietic origin, but not on thymic epithelium. J. Immunol. 147: 1222-1229.
61. Serreze, D. V., Osborne, M. A., Chen, Y.-G., Chapman, H. D., Pearson, T., et al. (2006) Partial versus full allogeneic hemopoietic chimerization is a preferential means to inhibit type 1 diabetes as the latter induces generalized immunosuppression. J. Immunol. 177, 6675-6684. (Pubitemid 44715031)
62. Seung, E., Iwakoshi, N., Woda, B. A., Markees, T. G., Mordes, J. P., et al. (2000) Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in isletallografted NOD/Lt mice. Blood 95, 2175-2182. (Pubitemid 30151663)
63. Serreze, D. V., Holl, T. M., Marron, M. P., Graser, R. T., Johnson, E. A., et al. (2004) MHC class II molecules play a role in the selection of autoreactive class I restricted CD8 T cells that are essential contributors to type 1 diabetes development in NOD mice. J. Immunol. 172, 871-879. (Pubitemid 38113744)
64. Shultz, L. D., Ishikawa, F. and Greiner, D. L. (2007) Humanized mice in translational biomedical research. Nat. Rev. Immunol. 7, 118-130. (Pubitemid 46174859)
65. King, M., Pearson, T., Shultz, L. D., Leif, J., Bottino, R., et al. (2008) A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin. Immunol. 126, 303-314.
66. Ishikawa, F., Yasukawa, M., Lyons, B., Yoshida, S., Miyamoto, T., et al. (2005) Development of functional human blood and immune systems in NOD/SCID/IL2-chainnull mice. Blood 106, 1565-1573.